SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012067
Filing Date
2022-08-04
Accepted
2022-08-04 08:01:21
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ewtx-20220630x10q.htm   iXBRL 10-Q 1996049
2 EX-31.1 ewtx-20220630xex31d1.htm EX-31.1 16966
3 EX-31.2 ewtx-20220630xex31d2.htm EX-31.2 17240
4 EX-32.1 ewtx-20220630xex32d1.htm EX-32.1 7532
5 EX-32.2 ewtx-20220630xex32d2.htm EX-32.2 7609
  Complete submission text file 0001558370-22-012067.txt   6102016

Data Files

Seq Description Document Type Size
6 EX-101.SCH ewtx-20220630.xsd EX-101.SCH 31856
7 EX-101.CAL ewtx-20220630_cal.xml EX-101.CAL 35308
8 EX-101.DEF ewtx-20220630_def.xml EX-101.DEF 148242
9 EX-101.LAB ewtx-20220630_lab.xml EX-101.LAB 335990
10 EX-101.PRE ewtx-20220630_pre.xml EX-101.PRE 257895
46 EXTRACTED XBRL INSTANCE DOCUMENT ewtx-20220630x10q_htm.xml XML 879338
Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40236 | Film No.: 221134775
SIC: 2834 Pharmaceutical Preparations